My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

BioLineRx Ltd. - American Depositary Shares (NQ:BLRX)

1.685 -0.025 (-1.46%)

Delayed Quote Updated: 2:07 PM EST, Nov 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioLineRx Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

BioLineRx (BLRX) Q1 2026 Earnings Transcript ↗

May 29, 2026

BioLineRx (BLRX) Q1 2026 Earnings Transcript

Via The Motley Fool

Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings ↗

March 20, 2026

BioLineRx Ltd. (NASDAQ: BLRX) to release Q4 earnings on March 23. Previous Q3 losses were 22 cents per share, with sales of $427,000. Analysts rate the stock favorably.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 16, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Examining the Future: BioLine Rx's Earnings Outlook ↗

August 13, 2025

Via Benzinga

A Look at BioLine Rx's Upcoming Earnings Report ↗

May 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 19, 2025

Via Benzinga

Where BioLine Rx Stands With Analysts ↗

June 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 09, 2025

Via Benzinga

Uncovering Potential: BioLine Rx's Earnings Preview ↗

March 28, 2025

Via Benzinga

3 Stocks Getting Rare Double Upgrades From Analysts

June 06, 2025

These three stocks have received a rare double upgrade from analysts since their most recent earnings reports; fortunately investors still have time to catch up

Via MarketBeat

Topics Economy

Here are the top movers in Monday's session. ↗

June 02, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 02, 2025

Via Benzinga

Dow Edges Higher; Dell Shares Fall After Q1 Results ↗

May 30, 2025

Via Benzinga

Topics Stocks

Why Is Nano-Cap BioLineRx Stock Surging On Friday? ↗

May 30, 2025

BioLineRx shares new data from its Phase 2 pancreatic cancer trial, showing strong response rates and durable outcomes with motixafortide combination.

Via Benzinga

BioLineRx Stock Jumps On Positive Data from Pilot Phase Of Pancreatic Cancer Drug Trial: Retail Cheers The ‘Buy’ Rating ↗

May 30, 2025

The company said that updated results from the pilot phase indicate that four of eleven patients remained disease progression-free after more than one year.

Via Stocktwits

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 30, 2025

Via Benzinga

The CHIPS Act and Peraso Inc. (NASDAQ: PRSO): Advancing Semiconductor Innovation and National Security – More Stocks Inside

May 30, 2025

Via AB Newswire

Topics Economy Supply Chain

Nasdaq Down 100 Points; Chicago PMI Dips In May ↗

May 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 30, 2025

Via Benzinga

Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗

May 30, 2025

Via Benzinga

BioLineRx Q1 Earnings Rise Despite Fall In Revenue: Retail Stays Super Confident ↗

May 27, 2025

CEO Philip Serlin said that the company has been actively evaluating new assets in the areas of oncology and rare diseases, where it can leverage its expertise after out-licensing Aphexda.

Via Stocktwits

Topics Lawsuit

Earnings Scheduled For May 27, 2025 ↗

May 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 02, 2025

Via Benzinga

Earnings Scheduled For March 31, 2025 ↗

March 31, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

January 30, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

Top stock movements in today's session. ↗

January 30, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

January 30, 2025

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition